Although ongoing advancements in insulin therapy have improved management of T1D, insulin therapy does not fully prevent complications, and patients with T1D have an increased risk of cardiovascular disease [77], foot ulcers and amputations, diabetic retinopathy [78], and kidney failure [79]. This evidence concerns the gene INS and cardiovascular disorder.